Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...
Hims & Hers Health Inc. shares surged as much as 18% and are on track to close at fresh record after Hunterbrook Media said the company is poised to be a major beneficiary of President-elect Donald ...
Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...
President-elect Donald Trump plans to nominate Marty Makary to lead the ... What To Know: Market optimism surrounding Makary's selection may have bolstered Hims & Hers shares on Monday as ...
(Bloomberg) -- Hims & Hers Health Inc. shares surged 24 ... beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration.
Hims & Hers Health Inc. shares surged as much ... major beneficiary of President-elect Donald Trump’s nomination of Marty Makary to lead the Food and Drug Administration. Hunterbrook said ...
Mr. Trump nominated Marty Makary, MD, on Nov. 22 to head the FDA ... Shares of virtual care company Hims & Hers spiked after the news that a telehealth ally could be running the FDA, Bloomberg ...